Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
Open Access
- 10 August 2018
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 78 (16) , 1299-1310
Abstract
Background: Prostate cancer (PCa) is one of the most malignant tumors of the male urogenital system. There is an urgent need to identify novel biomarkers for PCa.Methods: In this study, we evaluated the expression levels of MCM10 in prostate cancer by analyzing public datasets (including The Cancer Genome Atlas and GSE21032). Furthermore, loss of function assays was performed to evaluate the effects of MCM10 on cell proliferation, apoptosis, and colony formation. Furthermore, we performed microarray and bioinformatics analyses to explore the potential mechanisms of MCM10.Results: In the present study, we for the first time revealed MCM10 was significantly upregulated in PCa. Moreover, we found increased MCM10 expression was significantly associated with advanced clinical stage and high Gleason score PCa. Kaplan‐Meier analysis demonstrated higher MCM10 expression was associated with a poorer patient prognosis in PCa. Furthermore, loss of function assays showed that MCM10 knockdown inhibited cell proliferation and colony formation, but promoted cell apoptosis. Additionally, we performed microarray and bioinformatics analysis and found MCM10 regulated PCa progression by regulating a series of biological processes including cancer, cell death, and apoptosis.Conclusions: These results suggest that MCM10 may be a potential diagnostic and therapeutic target for PCa.Keywords
Funding Information
- Jiangsu Province Youth Medical Key Talent Program (QNRC2016457)
- Social Development Plan of Jiangsu Province-Standardization of Key Disease Diagnosis and Treatment Projects (BE2016715)
This publication has 33 references indexed in Scilit:
- The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikisOncotarget, 2016
- MCM10 overexpression implicates adverse prognosis in urothelial carcinomaOncotarget, 2016
- Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancerOncotarget, 2016
- PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational studyBMC Cancer, 2016
- Re: The Molecular Taxonomy of Primary Prostate CancerEuropean Urology, 2016
- Targeting Mitosis in Cancer: Emerging StrategiesMolecular Cell, 2015
- CRL4–DDB1–VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10Nucleic Acids Research, 2012
- TP53 gene mutations in prostate cancer progression.2010
- Wnt signalling and prostate cancerProstate Cancer and Prostatic Diseases, 2005
- DNA helicase deficiencies associated with cancer predisposition and premature ageing disordersHuman Molecular Genetics, 2001